Search Results - "Krumpl, Guenther"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Open-Label Two-Dose Pilot Study of Landiolol for the Treatment of Atrial Fibrillation/Atrial Flutter in Caucasian Patients by Stix, Guenter, Wolzt, Michael, Domanovits, Hans, Kadlecová, Pavla, Husch, Bernhard, Trebs, Michaela, Hodisch, Juri, Unger, Martin, Krumpl, Guenther

    Published in Circulation Journal (25-12-2019)
    “…Background:We investigated for the first time the suitability of landiolol, an ultra-short-acting β1-specific β-blocker, for the treatment of atrial…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group by Krumpl, Günther, Ulc, Ivan, Trebs, Michaela, Kadlecová, Pavla, Hodisch, Juri

    Published in European journal of clinical pharmacology (01-04-2017)
    “…Purpose The aim of this prospective study was to compare in non-Asian subjects the pharmacokinetics (PK), pharmacodynamics (PD), safety, and tolerability of…”
    Get full text
    Journal Article
  6. 6

    Pharmacodynamic and -kinetic Behavior of Low-, Intermediate-, and High-Dose Landiolol During Long-Term Infusion in Whites by Krumpl, Günther, Ulč, Ivan, Trebs, Michaela, Kadlecová, Pavla, Hodisch, Juri, Maurer, Gabriele, Husch, Bernhard

    Published in Journal of cardiovascular pharmacology (01-07-2017)
    “…Pharmacokinetics, pharmacodynamics, safety, and tolerability of long-term administration of landiolol, a fast-acting cardioselective β-blocker, were…”
    Get full text
    Journal Article
  7. 7

    Pharmacokinetics and Pharmacodynamics of Low-, Intermediate-, and High-Dose Landiolol and Esmolol During Long-Term Infusion in Healthy Whites by Krumpl, Günther, Ulč, Ivan, Trebs, Michaela, Kadlecová, Pavla, Hodisch, Juri, Maurer, Gabriele, Husch, Bernhard

    Published in Journal of cardiovascular pharmacology (01-03-2018)
    “…The pharmacokinetics, pharmacodynamics, safety, and tolerability of long-term administration of esmolol and landiolol, a new fast-acting cardioselective…”
    Get full text
    Journal Article
  8. 8

    Pharmacokinetics and pharmacodynamics of two different landiolol formulations in a healthy Caucasian group by Krumpl, Günther, Ulc, Ivan, Trebs, Michaela, Kadlecová, Pavla, Hodisch, Juri

    “…To date, no data have been reported on the pharmacokinetic and pharmacodynamic properties of landiolol, a fast-acting cardioselective β1-adrenergic antagonist,…”
    Get full text
    Journal Article
  9. 9

    Dobutamine Alters the Pharmacokinetic and Pharmacodynamic Behavior of Esmolol by Krumpl, Günther, Ulč, Ivan, Trebs, Michaela, Hodisch, Juri, Kadlecová, Pavla, Husch, Bernhard

    Published in Curēus (Palo Alto, CA) (22-12-2020)
    “…Background and objective This study involved an investigation into the pharmacokinetic and pharmacodynamic behavior of esmolol in the presence of dobutamine in…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Naltrexone (50 mg) Plus Psychotherapy in Alcohol-Dependent Patients: A Meta-Analysis of Randomized Controlled Trials by Jarosz, Joanna, Miernik, Katarzyna, W chal, Maria, Walczak, Jacek, Krumpl, Günther

    “…Background: Alcoholism is a chronic and potentially fatal disease. One of the therapeutic options is pharmacotherapy with the opioid antagonist naltrexone in…”
    Get full text
    Journal Article
  12. 12